United States · 
What does Epidarex Capital invest in?
Epidarex Capital invests most often at Series A and Series B (100% of the rounds on record), in sectors such as Proteomics, In Vitro Diagnostics and Diagnostics.
Epidarex Capital highlights
- 01
2 cheques in the last 12 months
- 02
Mostly Series A and Series B: 100% of its rounds
- 03
Sole investor in 3 rounds, median $2.5M
What they do
EPIDAREX IS A TRANSATLANTIC VENTURE CAPITAL FIRMFrom their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries BGrowth
- Sectors
- ProteomicsIn Vitro DiagnosticsDiagnostics
- Based in
- Bethesda, United States
- Cold pitches
- Accepted
The record
Every round we can evidence, newest first15 appearances
- 2026
2 rounds
- Oct
- Jul
- 2024
1 round
- Sept
- 2022
1 round
- Mar
- 2021
1 round
- Jun
- 2019
1 round
- Nov
- 2018
1 round
- Jun
- 2015
5 rounds
- Nov
- Jul
- May
- Apr
- Feb
- 2014
3 rounds
- Dec
- Feb
- Feb
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration2 named
ASAndrew Sinclair DunlopManaging MemberiForm ADV
KKKyparissia Katie SirinakisManaging MemberiForm ADV
We also hold 9 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$17Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- Epidarex Capital Management LLC
- SEC number
- CRD 307874
What they claim to have backed
From their own portfolio page (on their website)
12 of 20 we have independently watched raise
CaldantherapeuticsEnterprisetherapeuticsEpsilogenLibratherapeuticsLunactherapeuticsMacomicsMironidNodtheraNyramedicalRymemedicalSlatebioTheolyticsApellisClydebioDunadEdinimageKodikazLeucidRapidpulsemedTopas-therapeutics
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.